ESWT

ESWT

Equipment
ESWT
ESWT

Information

Extracorporeal Shockwave Therapy (ESWT) is a safe, innovative, cost-effective and non-invasive treatment with convincing evidence of its effectiveness from numerous research and clinical trials. The main benefits of shockwave therapy are relief of pain and restoration of function. Shockwave therapy has been shown to be an effective treatment for a number of common tendon complaints, including plantar fasciitis, Achilles tendinopathy, and tennis elbow. Today, ESWT applications are a frequently preferred method in the fields of veterinary medicine, neurology, urology, cardiology, sports medicine, temporomandibular joint pain in dentistry, dermatology and aesthetics, but especially in orthopedics and physical therapy. Advantages of this system are; provides a faster tissue healing by increasing vascularization, collagen synthesis and oxygenation in the tissue, develops less adhesiveness and provides a mechanically stronger tissue. Because of non-invasive treatment method of ESWT, there is no need to surgical intervention. After sessions lasting an average of 20 minutes, the patient can continue his/her daily routine.
Young-in Biotech Co., Ltd.Z6.A15Youngin Biotech was founded in 2007 and aims to develop cutting-edge medical devices for a healthy and happy life, and experts with decades of know-how and experience in each field work together. In particular, we are developing products that can increase customer satisfaction by utilizing cutting-edge technology through a company-affiliated research center established in 2020. Even now, we are pursuing continuous quality improvement using AIMS 3, an ultrasonic sound field analysis and measurement system, by deploying professional personnel. Youngin Biotech is rapidly listing in the domestic and international extracorporeal shock wave (ESWT, Extracorporeal Shockwave Therapy) markets. While the domestic and international extracorporeal shock wave market was dominated by foreign companies, Youngin Biotech created a new wave in the market with its Array Piezo model, which delivers powerful shocks to a focal point by precisely combining about 200 piezoelectric elements. Since then, we have introduced the Youngin Biotech brand to the global market by launching the Thorsewave, a pneumatic radial shock wave, and more recently, the Surperstars+ model, which is equipped with a linear method that delivers uniform energy shock waves to a 3D focal area. Youngin Biotech’s history is full of innovation and effort. Starting from a small office, we have grown into Korea's top cutting-edge extracorporeal shock wave manufacturing company through nearly 20 years of trial and error and success. This is because we have focused our efforts on developing good products by paying attention to market needs. We participated in this exhibition as an opportunity to launch a new product by developing a new extracorporeal shock wave for animals, positioning ourselves in the Middle East, North American, and European markets in particular.

Join the event!